You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm said it took in $33.6 million in product and service revenue in the quarter, a 42 percent increase from $23.6 million in Q4 2018.
Oslo-based InstruNor's systems will enable Fluidigm to offer fully automated, walkaway sample preparation for flow and mass cytometry.
With the partnership, the companies aim to help researchers streamline their workflows from sample collection to enrichment to interpretation.
The company is currently looking for beta customers to test the system for whole-genome sequencing, exome sequencing, and RNA-seq library prep workflows.
The Cambridge, Massachusetts-based firm also said it tacked on $3 million to its Series B financing round for a total of $30 million.
The collaboration will combine Twist's target enrichment and sample library preparation kits and Miroculus' Miro Canvas microfluidics system.
The company is developing an RNA sequencing kit based on a technology that enables barcoding in a test tube format to prepare samples for single-cell profiling.
The company plans to offer four new products by the end of the year, including four targeted transcriptomic panels and IHC compatibility for Visium.
North Carolina-based BioSkryb develops sample preparation kits based on proprietary primary template-directed amplification chemistry.
LGC will be Swift's worldwide partner for amplicon-based targeted sequencing assays for genotyping AgBio samples, including crop species and animals.
GenapSys will offer the Twist Bioscience products to customers of its recently launched low-cost, portable DNA sequencing system.
S2 Genomics' Singulator platform combines enzymatic and mechanical disruption to produce suspensions of cells or nuclei for downstream applications.
Though 10x will phase out its linked reads technology, it plans to introduce targeted RNA-seq for Chromium and FFPE sample compatibility for Visium.
The commission plans to bar Bio-Rad from importing certain single-cell products, potentially including the ddSeq Single-Cell Isolator and ddSeq cartridges.
The high-throughput S2000 sequencer is the second instrument Genetron Health has received NMPA approval for, following the S5 benchtop instrument last year.
All three methods build on the use of methyltransferases to mark accessible regions of the genome, using nanopore sequencing to detect the modifications.
The UK's Biosearch Technologies will distribute Arbor Biosciences' myBaits custom, targeted NGS panels to agricultural and seed breeding companies.
Unlike the Hi-C chromosome conformation assay, the Pore-C technique reveals information that's lost with short-read sequencing.
QCMD said it will use the technology to develop new reagents for use with its own molecular infectious disease proficiency testing solutions.
The firm's whole-genome amplification chemistry may help researchers better understand cancer heterogeneity, even between cells.
President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.
A study of Great Danes homes in on a genomic region linked to fearfulness.
CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.
In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.